Author

Elisa Melon-Ardanaz

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain;

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adria Caballe· 1 shared Alex Cebria-Xart· 1 shared Alexandra AvgustinovaiD· 1 shared Alicia Castaneda· 1 shared Andrea Onieva· 1 shared Andrea UrpiiD· 1 shared Anna Pascual-Reguant· 1 shared Carlos J. Rodriguez Hernandez· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adria Caballe

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 4, 2026

MET inhibition exploits conserved regulatory dependencies in malignant rhabdoid tumors

Ines Sentis, Alex Cebria-Xart, Quirze Rovira…·Alexandra Avgustinova

This study identifies MET signaling as a targetable vulnerability in rhabdoid tumors through integrated single-cell multi-omic and spatial transcriptomics analyses.

DOI 10.64898/2026.11.03.763704

humanscRNA-seq

𝕏 PostBluesky